As filed with the Securities and Exchange Commission on March 28, 2025
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Genelux Corporation
(Exact name of registrant as specified in its charter)
Delaware | 77-0583529 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
2625 Townsgate Road, Suite 230 Westlake Village, California 91361 |
91361 | |
(Address of Principal Executive Offices) | (Zip Code) |
2022 Equity Incentive Plan
2022 Employee Stock Purchase Plan
(Full titles of the plans)
Thomas Zindrick, J.D.
President and Chief Executive Officer
Genelux Corporation
2625 Townsgate Road, Suite 230
Westlake Village, California 91361
(805) 267-9889
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Jason L. Kent
Christine S. Kim
Cooley LLP
10265 Science Center Drive
San Diego, California 92121
(858) 550-6000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
Emerging growth company | ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
This Registration Statement on Form S-8 is being filed by Genelux Corporation (the “Registrant”) for the purpose of registering (i) an additional 1,729,664 shares of Registrant’s Common Stock, par value $0.0001 per share (“Common Stock”), under the Registrant’s 2022 Equity Incentive Plan (the “2022 Plan”) pursuant to the provisions of the 2022 Plan providing for an automatic increase in the number of shares of Common Stock reserved and available for issuance under the 2022 Plan and (ii) 345,932 additional shares of Common Stock under the Registrant’s 2022 Employee Stock Purchase Plan (the “2022 ESPP”) pursuant to the provisions of the 2022 ESPP providing for an automatic increase in the number of shares of Common Stock reserved and available for issuance under the 2022 ESPP.
PART II
ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE.
The following documents filed by the registrant with the Securities and Exchange Commission (SEC) are incorporated by reference into this registration statement:
● | the contents of the Registration Statements on Form S-8 previously filed with the Commission on January 26, 2023 and March 29, 2024; |
● | the registrant’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 28, 2025; and |
● | the description of the registrant’s common stock contained in the registrant’s registration statement on Form 8-A, filed with the SEC on January 23, 2023, including any amendments or reports filed for the purpose of updating such description, including Exhibit 4.16 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2024. |
All reports and other documents filed by the registrant pursuant to Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, other than Current Reports furnished under Item 2.02 or Item 7.01 of exhibits furnished on such form that relate to such items and other portions of documents that are furnished but not filed or are otherwise not incorporated into registration statements pursuant to the applicable rules promulgated by the SEC, after the date of this registration statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part of this registration statement from the date of filing such reports and documents. Any statement contained in a document incorporated or deemed to be incorporated herein by reference shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes that statement. Any such statement so modified or superseded shall not constitute a part of this registration statement, except as so modified or superseded.
Item 8. | Exhibits. |
The exhibits to this Registration Statement are listed below:
* Filed herewith
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Westlake Village, State of California, on March 28, 2025.
GENELUX CORPORATION | ||
By: | /s/ Thomas Zindrick, J.D. | |
Thomas Zindrick, J.D. | ||
President and Chief Executive Officer |
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Thomas Zindrick, J.D and Matthew Pulisic, and each of them as his or her true and lawful attorneys-in-fact and agents, each with full power of substitution and resubstitution, for him or her and in their name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to sign any registration statement for the same offering covered by this registration statement that is to be effective on filing pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and all post-effective amendments thereto, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Signature |
Title |
Date | ||
/s/ Thomas Zindrick, J.D. |
President, Chief Executive Officer and Chairman of the Board |
March 28, 2025 | ||
Thomas Zindrick, J.D. | (Principal Executive Officer) | |||
/s/ Matthew Pulisic |
Chief Financial Officer |
March 28, 2025 | ||
Matthew Pulisic | (Principal Financial and Accounting Officer) | |||
/s/ Mary Mirabelli |
Director | March 28, 2025 | ||
Mary Mirabelli | ||||
/s/ John Smither |
Director | March 28, 2025 | ||
John Smither | ||||
/s/ James L. Tyree |
Director | March 28, 2025 | ||
James L. Tyree | ||||
/s/ John Thomas, Ph.D. |
Director | March 28, 2025 | ||
John Thomas, Ph.D. |